Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

West Pharmaceutical Services WST is scheduled to release first-quarter 2025 results on April 24, before the opening bell. In ...

Buying $1000 In GMED: If an investor had bought $1000 of GMED stock 10 years ago, it would be worth $2,782.28 today based on a price of $71.01 for GMED at the time of writing.

Globus Medical, Inc. (NYSE: GMED) will release its first-quarter 2025 financial results on Thursday, May 8, 2025, after ...

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...